Hui-Ju Ch’ang

555 total citations
38 papers, 429 citations indexed

About

Hui-Ju Ch’ang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hui-Ju Ch’ang has authored 38 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hui-Ju Ch’ang's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). Hui-Ju Ch’ang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). Hui-Ju Ch’ang collaborates with scholars based in Taiwan, United States and Japan. Hui-Ju Ch’ang's co-authors include Li‐Tzong Chen, Yu‐Hsiang Sung, Shang‐Da Huang, Chiun Hsu, Patrick C.H. Hsieh, Chi‐Feng Hung, Tran‐Der Tan, Skye Hongiun Cheng, Yen‐Feng Chiu and Hiromitsu Nakauchi and has published in prestigious journals such as PLoS ONE, Biomaterials and Circulation Research.

In The Last Decade

Hui-Ju Ch’ang

34 papers receiving 423 citations

Peers

Countries citing papers authored by Hui-Ju Ch’ang

Since Specialization

Citations

This map shows the geographic impact of Hui-Ju Ch’ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Ju Ch’ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Ju Ch’ang more than expected).

Fields of papers citing papers by Hui-Ju Ch’ang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui-Ju Ch’ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Ju Ch’ang. The network helps show where Hui-Ju Ch’ang may publish in the future.

Co-authorship network of co-authors of Hui-Ju Ch’ang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui-Ju Ch’ang. A scholar is included among the top collaborators of Hui-Ju Ch’ang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui-Ju Ch’ang. Hui-Ju Ch’ang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Neoadjuvant Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma—A Systematic Review and Meta-Analysis 2025 ·International Journal of Radiation OncologyBiologyPhysics ·Hongyan Wu, Hsiao‐Hui Tsou, Long‐Sheng Lu, (unknown), (unknown), Hui-Ju Ch’ang	1
2	Krüppel-like Factor 10 as a Prognostic and Predictive Biomarker of Radiotherapy in Pancreatic Adenocarcinoma 2023 ·Cancers ·(unknown), (unknown), Ruijun Liu, Tingwei Li, Hui-Ju Ch’ang	0
3	Krüppel-like factor 10 modulates stem cell phenotypes of pancreatic adenocarcinoma by transcriptionally regulating notch receptors 2023 ·Journal of Biomedical Science ·(unknown), (unknown), Shih Sheng Jiang, John R. Hawse, (unknown), (unknown), Tze‐Sing Huang, Hui-Ju Ch’ang	5
4	Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy 2023 ·Radiation Oncology ·I‐Shiow Jan, Hui-Ju Ch’ang	6
5	Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer 2023 ·Lung Cancer ·Hsiu‐Ying Ku, (unknown), Chih‐Liang Wang, Yuan‐Ting C. Lo, Cheng‐Shyong Chang, Gee‐Chen Chang, Hui-Ju Ch’ang, Tsang‐Wu Liu	2
6	High BRCA1 gene expression increases the risk of early distant metastasis in ER+ breast cancers 2022 ·Scientific Reports ·Hui-Ju Ch’ang, Ueng‐Cheng Yang, (unknown), Chen‐Hsin Chen, (unknown)	8
7	A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study 2021 ·British Journal of Cancer ·Yung‐Yeh Su, Yen‐Feng Chiu, Chung‐Pin Li, Shih‐Hung Yang, Johnson Lin, Shyh‐Jer Lin, Ping‐Ying Chang, Nai‐Jung Chiang, Yan‐Shen Shan, Hui-Ju Ch’ang, Li‐Tzong Chen	15
8	Upregulating sirtuin 6 ameliorates glycolysis, EMT and distant metastasis of pancreatic adenocarcinoma with krüppel-like factor 10 deficiency 2021 ·Experimental & Molecular Medicine ·(unknown), Suliang Chen, (unknown), Ya-Li Tsai, (unknown), (unknown), Hui-Ju Ch’ang	12
9	Therapeutic Effect of Repurposed Temsirolimus in Lung Adenocarcinoma Model 2018 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), Yen‐Kuang Lin, Yen‐Hung Chow, Hui-Ju Ch’ang, Vincent H.S. Chang	7
10	Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype 2017 ·PLoS ONE ·(unknown), (unknown), (unknown), Li‐Yu Wang, Yen‐Hung Chow, Shih Sheng Jiang, Hui-Ju Ch’ang, Vincent H.S. Chang	6
11	The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis 2017 ·Cancer Research and Treatment ·Jeffrey S. Chang, Yen‐Feng Chiu, (unknown), Li‐Tzong Chen, Hui-Ju Ch’ang	16
12	Bone marrow derived macrophages fuse with intestine stromal cells and contribute to chronic fibrosis after radiation 2016 ·Radiotherapy and Oncology ·(unknown), Ya-Hui Chang, (unknown), Suliang Chen, Tze‐Sing Huang, (unknown), Hui-Ju Ch’ang	16
13	Optimal combination of antiangiogenic therapy for hepatocellular carcinoma 2015 ·World Journal of Hepatology ·Hui-Ju Ch’ang	8
14	Sexual genetic and simple sequence repeat (SSR) analysis for molecular marker development on the all hermaphrodite papaya 2015 ·Genetics and Molecular Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), W. C. Chung, (unknown), Hui-Ju Ch’ang, (unknown)	1
15	Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide 2014 ·Hepatology International ·Po‐Chin Liang, Hui-Ju Ch’ang, Chiun Hsu, Li‐Tzong Chen, Tiffany Ting‐Fang Shih, (unknown)	11
16	Induction Chemotherapy With Gemcitabine, Oxaliplatin, and 5-Fluorouracil/Leucovorin Followed by Concomitant Chemoradiotherapy in Patients With Locally Advanced Pancreatic Cancer: A Taiwan Cooperative Oncology Group Phase II Study 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Hui-Ju Ch’ang, Yulin Lin, Hsiu-Po Wang, (unknown), (unknown), Chih‐Hung Hsu, Yu‐Wen Tien, Jen‐Shi Chen, Ruey‐Kuen Hsieh, Pin-Wen Lin, Yan‐Shen Shan, Ann‐Lii Cheng, Jang‐Yang Chang, Jacqueline Whang‐Peng, Tsann-Long Hwang, Li‐Tzong Chen	19
17	Analysis by virus induced gene silencing of the expression of two proline biosynthetic pathway genes in Nicotiana benthamiana under stress conditions 2011 ·Plant Physiology and Biochemistry ·Hsin‐Mei Ku, (unknown), Hui-Ju Ch’ang, (unknown), Fuh‐Jyh Jan, C. T. Chen	13
18	Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result 2007 ·Liver International ·Po‐Chin Liang, Hui-Ju Ch’ang, Chiun Hsu, (unknown), Tiffany Ting‐Fang Shih, (unknown)	13
19	Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study 2005 ·Gynecologic Oncology ·Yih‐Lin Chung, James Jer‐Min Jian, Skye Hongiun Cheng, (unknown), Tran‐Der Tan, Hui-Ju Ch’ang, Chi‐Feng Hung, Cheng‐Fang Horng, (unknown), Mei-Hua Tsou	62
20	Angioimmunoblastic Lymphadenopathy with Dysproteinemia – Lack of a Prognostic Value of Clear Cell Morphology 1997 ·Oncology ·Hui-Ju Ch’ang, Ih‐Jen Su, (unknown), (unknown), Yee‐Chun Chen, (unknown), Ann‐Lii Cheng	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact